IL-6 signals inhibition of cell adhesion in melanoma A375-C6

Anticancer Research

Volumn 16, Issue 6 B, 1996, Pages 3363-3370

  Schwabe, Michael ^a,c   Deryugina, Elena I ^b   Bosco, Maria Carla ^a   Gusella, Gabriele L ^a   Reinisch, Walter ^a   Kung, Hsiang F U ^a   Bourdon, Mario A ^a,b,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b La Jolla Institute for Experimental Medicine   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

^d San Diego Inst for Exptl Medicine   (United States)

Author keywords

Adhesion; Cytokines; Extracellular matrix proteins; Fibronectin; Interleukin 6; Melanoma; Proliferation; Tenascin

Indexed keywords

COLLAGEN; FIBRONECTIN; INTEGRIN; LAMININ; RECOMBINANT INTERLEUKIN 6; TENASCIN;

ARTICLE; CELL ADHESION; CELL CLONE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL SHAPE; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MELANOMA; METASTASIS POTENTIAL; PRIORITY JOURNAL;

ANTIGENS, CD; CELL ADHESION; CELL DIVISION; DOWN-REGULATION; FIBRONECTINS; GROWTH INHIBITORS; HUMANS; INTEGRINS; INTERLEUKIN-6; MELANOMA; NEOPLASM PROTEINS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-6; TENASCIN; TUMOR CELLS, CULTURED;

EID: 0030485692     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kishimoto T: The biology of interleukin-6. Blood 74: 1-10, 1989.
2. VanSnick J: Interleukin-6: an overview. Ann Rev Immunol 8: 253-278, 1990.
3. Sehgal PB: Interleukin-6: molecular pathophysiology. J Invest Dermatol 94: 2S-6S, 1990.
4. Chen L, Mory Y, Ziberstein A and Revel M: Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-β2. Proc Natl Acad Sci 85: 8037-8041, 1988.
5. Satoh T, Nakamura S, Taga T, Matsuda T, Hirano T, Kishimoto T and Kaziro Y: Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin-6. Mol Cell Biol 8: 3546-3549, 1988.
6. Tamm I, Cardinale I, Krueger J, Murphy JS, May LT and Sehgal PB: Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med 170: 1649-1669, 1989.
7. Chiu CP, Lee F, Ferro T J, Johnson A, Everitt J and Malik A: B. IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells. J Immunol 142: 1909-1915, 1989.
8. Mule JJ, Custer MC, Travis WD and Rosenberg SA: Cellular mechanism of the antitumor activity of recombinant IL-6 in mice. J Immunol 148: 2622-2629, 1992.
9. Givon T, Slavin S, Haran-Ghera N, Michalevicz R and Revel M: Antitumor effects of recombinant human interleukin-6 in acute myeloid leukemia in mice and in cell cultures. Blood 79: 2392-2398, 1992.
10. Armstrong CA, Murray N, Kennedy M, Koppula SV, Tara D and Anse JC: Melanoma-derived interleukin 6 inhibits in vivo melanoma growth. J Invest Dermatol 102: 278-284, 1994.
11. Serve H, Steinhauser G, Oberberg D, Flegel WA, Northoff H and Berdel WE: Studies on the interaction between interleukin 6 and human malignant nonhematopoietic cell lines. Cancer Res 51:3862-3866, 1991.
12. Morinaga Y, Suzuki H, Takatsuki F, Alkiyama Y, Taniyama T, Matsushima K and Onozaki K: Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines. J Immunol 143: 3538-3542, 1989.
13. Lu C, Vickers MF and Kerbel RS: Interleukin 6: A fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci 89: 9215-9219, 1992.
14. Lu C and Kerbel RS: Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol 120: 1281-1288, 1993.
15. Kishimoto T, Akira S and Taga T: Interleukin-6 and its receptor: A paradigm for cytokines. Science. 258: 593-597, 1992.
16. Juliano R L and Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 120: 577-585, 1993.
17. Kozlowski JM, Hart IR, Fidler IJ and Hana N: A human melanoma cell line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Can Inst 72: 913-917, 1984.
18. 1 and ανβ3 integrins. J Cell Sci 105: 1001-1012, 1993.
19. Ruoslahti E, Hayman EG, Pierschbacher M and Engvall E: Fibronectin: Purification, immunochemical properties, and biological activities. Meth Enzymol 82: 803-831, 1982.
20. Bourdon MA, Wikstrand CJ, Furthmayer H, Mattews TJ and Bigner DD: Human glioma-mesenchimal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 43: 2796-2806, 1983.
21. Hibi M, Murakami M, Saito M, Hirano T, Taga T and Kishimoto T: Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63: 1149-1157, 1990.
22. Schwabe M, Zhao J and Kung H-f: Differential expression and ligand-induced modulation of the human interleukin-6 receptor on interleukin-6-responsive cells. J Biol Chem 269: 7201-7209, 1994.
23. Vindelov LL, Christensen II and Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983.
24. Herlyn M, Graeven U, Speicher D, Sela B-A, Bennicelli J, Kath R and Iv DO: Characterization of tenascin secreted by human melanoma cells. Cancer Res 57:4853-4858, 1991.
25. Pearson CA, Pearson D, Shibahara S, Hofsteenge J and Chiquet-Ehrismann R, Tenascin: cDNA cloning and induction by TGF-β. EMBO J 7: 2677-2681, 1988.
26. Sharifi BG, LaFleur DW, Pirola CJ, Forrester JS and Fagin JA: Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. J Biol Chem 267: 23910-23915, 1992.
27. Tucker RP, Hammarback JA, Jenrath DA, Mackie EJ and Xu Y: Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J Cell Sci 104: 69-76, 1993.
28. McCachren SS and Lightner VA: Expression of human tenascin in synovitis and its regulation by interleukin-1. Arthritis Rheum 35: 1185-196, 1992.
29. Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K and Chiquet M: Tenascin interferes with fibronectin action. Cell 53: 383-390, 1988.
30. Sriramarao P and Bourdon MA: Melanoma cell invasive and metastatic potential correlates with endothelial cell reorganization and tenascin expression. Endothelium 4: 85-97, 1996.
31. Deryugina EI and Bourdon MA: Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Sci 109:643-652, 1996.
32. Hagiwara T, Suzuki H, Kono I, Kashiwagi H, Akiyama Y and Onozaki K: Regulation of fibronectin synthesis by interleukin-1 and interleukin-6 in rat hepatocytes. Amer J Pathol 136: 39-47, 1989.